A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD)...
Von Willebrand Disease (VWD)The main aim of this study is to estimate the risks of certain adverse events in adults with Von Willebrand Disease treated with VEYVONDI. No study medicines will be provided to participants in this study. Data from medical records of participants diagnosed with Von Willebrand Disease and treated with VEYVONDI will be evaluated during this study.
Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease
Von Willebrand DiseaseThis is an observational study, hence there is no study hypothesis
The Von Willebrand Disease (VWD) International Prophylaxis Study
Von Willebrand DiseaseThe von Willebrand Disease Prophylaxis Network (VWD PN) is an international study group formed with the goal of investigating the role of prophylaxis in clinically severe VWD that is non-responsive to other treatment(s).
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
Von Willebrand DiseasesThe purpose of this study is to prospectively obtain reliable data on the bleeding and treatment pattern of patients with VWD undergoing on-demand treatment with a VWF-containing product over a period of 6 months. The data obtained will be used as a basis for historical comparisons with the bleeding and treatment pattern obtained from a clinical study on the efficacy of prophylactic treatment with a VWF/FVIII concentrate.
A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
Von Willebrand DiseaseAs part of CSL Behring Canada's continued commitment to ensuring the safety of the new low volume preparation of Humate-P®, CSL Behring Canada proposes to conduct a prospective, multi-center structured data collection of routine management of patients with von Willebrand disease treated with Humate P® ivr in Canada. The surveillance will be non-interventional and non-experimental. During the observation period, the routine medical care of the patient will be documented. It is expected that there will be no difference in the safety and tolerability of Humate-P® ivr compared to Humate-P®
National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
Von Willebrand DiseaseThe objective of this study is to assess the clinical presentation, the treatment and the complications of the disease and treatment in moderate and severe von Willebrand disease. Another goal is to investigate the influence of von Willebrand disease on quality of life.
Willebrand International Non-interventional Global Surveillance
Von Willebrand DiseaseCollect information about WILLFACT or WILFACTIN in their real life clinical use and identify the therapeutic practices in an international environment.
Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
Von Willebrand DiseaseThe primary objective of this study is to describe characteristics and trends for thrombin generation (TG) and thromboelastography (TEG) at 4 time points during the menstrual cycle.
Changes in Bleeding and Clotting During the Menstrual Cycle
Von Willebrand's DisorderHealthyIndirect evidence suggests that hormonal fluctuations during the menstrual cycle also affect the bleeding and clotting system. This study looks at two sensitive laboratory tests at four time points during the menstrual cycle to determine if there is a natural variation in coagulation and platelet function. Laboratory tests in healthy subjects will be compared to women with von Willebrand's disorder type 1, a bleeding disorder. In the future, these laboratory tests may help in the diagnosis of bleeding and clotting disorders and to design treatments for women with abnormal menstrual bleeding.
The Effect of the Nutraceutical "Hemofix" on the Coagulation System
Von Willebrand DiseaseMenorrhagiaHemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.